Dr. Marshall and his wife Liza, share their unique story in this recently published book.
Search our current GI clinical trials offered through MedStar Georgetown
Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients
Learn more about this editorial collaboration between the Ruesch Center and Medscape
Dr. Marshall explains procedures MedStar and Georgetown have instituted to ensure your safety while you receive the best care possible Learn More
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Interview with Dr. John Marshall and Dr. Tony Shields on MI FOLFOXai™
January 8th, 2021
In this interview Dr. Marshall and Dr. Shields discuss the findings of their paper and how we can better predict which metastatic colorectal cancer patients will benefit from first-line FOLFOX+BV followed by FOLFIRI+BV or vice versa.
Ruesch Center Targets Gastrointestinal Cancers
December 9th, 2020
While her husband received treatment, Jeanne Ruesch saw firsthand the dishearteningly protracted pace of gastrointestinal cancer research. She was inspired by the care that she and her husband received from oncologist John Marshall, MD, but at the same time recognized a gaping need for a better understanding of GI cancers and how to treat them.
Disrupting the cellular process that promotes pancreatic cancer’s deadly growth
December 8th, 2020
In research part-funded by the Ruesch Center and published today in Gastroenterology, Georgetown’s Peran, Byers, et al. find a possible biomarker and mechanism for gemcitabine response in pancreas cancer.
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.
